Dr. Ardalan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1475 NW 12th Ave
Miami, FL 33136Phone+1 305-243-1000Fax+1 305-243-9927
Education & Training
University of London Faculty of MedicineClass of 1970
Certifications & Licensure
CA State Medical License 1980 - Present
FL State Medical License 1991 - 2025
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Combination Chemotherapy as First-Line Therapy in Treating Patients With Stage IV Gastric Cancer That Cannot Be Removed By Surgery Start of enrollment: 2005 Jun 01
- Combination Chemotherapy in Treating Patients With Previously Untreated Stage II or Stage III Esophageal Cancer That Can Be Removed By Surgery Start of enrollment: 2004 Oct 01
- Arsenic Trioxide, Fluorouracil, and Leucovorin in Treating Patients With Stage IV Colorectal Cancer That Has Relapsed or Not Responded to Treatment Start of enrollment: 2005 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 9 citationsCobimetinib Plus Gemcitabine: An Active Combination in KRAS G12R-Mutated Pancreatic Ductal Adenocarcinoma Patients in Previously Treated and Failed Multiple Chemothera...Bach Ardalan, Jose Ignacio Azqueta, Danny Sleeman
Journal of Pancreatic Cancer. 2021-10-14 - 11 citationsA Phase II Study of Neoadjuvant and Adjuvant Chemotherapy with 5-Fluorodeoxyuridine, Leucovorin, Oxaliplatin and Docetaxel in the Treatment of Previously Untreated Adv...Naveenraj L. Solomon, Dmitry Mezentsev, Isildinha M. Reis, Myra Lima, Joyce Rios
Japanese Journal of Clinical Oncology. 2011-04-01 - 22 citationsLong-term survival based on pathologic response to neoadjuvant therapy in esophageal cancer.Gregory Tiesi, Wungki Park, Meredith A. Gunder, Gustavo A. Rubio, Michael H. Berger
The Journal of Surgical Research. 2017-08-01
Grant Support
- Reversal Of 5-FU Resistance By Arsenic Trioxide In Colorectal CarcinomaNational Cancer Institute2007–2008
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
